Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Comparison of Outcomes between HSCT Donor Sources for Pediatric Patients with Hematologic Malignancies

Lauren Longo, Filippo Milano, MD PhD, Colleen Delaney, MD MSc, Marie Bleakley, MBBS, PhD MMSc, Lauri S Burroughs, MD, Brandon Hadland, MD PhD, Elisabetta Xue, MD, Laura Roberts, Soheil Meshinchi, MD PhD, Kanwaldeep K. Mallhi, MD, Monica Thakar, MD, K Scott Baker, MD MS, Corinne Summers, MD, Ann Dahlberg, MD

Blood (2019) 134 (Supplement_1): 4611.

https://doi.org/10.1182/blood-2019-126062

Published: 2019

Journal Articles

Individualized Treatment Summaries and Survivorship Care Plans (SCPs) for Hematopoietic Cell Transplant (HCT) Survivors Reduces Cancer Treatment Distress in a Randomized, Multicenter Study

Blood (2017) 130 (Supplement 1): 331.

https://doi.org/10.1182/blood.V130.Suppl_1.331.331

Published: 2017

Journal Articles

Lifestyle Factors and Subsequent Ischemic Heart Disease Risk after Hematopoietic Cell Transplantation

Kasey J Leger, MD MSc, K. Scott Baker, MD MS, Kara Cushing-Haugen, MS, Mary E. Flowers, MD, Wendy M. Leisenring, ScD, Paul J. Martin, MD, Jason A. Mendoza, MD MPH, Kerryn Reding, RN, PhD, Karen L. Syrjala, PhD, Stephanie J Lee, MD MPH, Eric J Chow, MD MPH

Blood (2017) 130 (Supplement 1): 3269.

https://doi.org/10.1182/blood.V130.Suppl_1.3269.3269

Published: 2017

Journal Articles

Effect of Dexrazoxane on Heart Function Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report from the Children's Oncology Group (COG)

Eric J Chow, MD MPH, David R. Doody, MS, Saro H. Armenian, DO, MPH, Sanjeev Aggarwal, MD, K. Scott Baker, MD MS, Smita Bhatia, MD MPH, Nancy A. Blythe, BA, Louis S. Constine, MD, David R. Freyer, DO, MS, Lisa M. Kopp, DO, Wendy M. Leisenring, ScD, Nao Sasaki, MD, Lynda M. Vrooman, MD MSc, Barbara L. Asselin, MD, Cindy L. Schwartz, MD MPH, Steven E. Lipshultz, MD FAAP, FAHA

Blood (2016) 128 (22): 696.

https://doi.org/10.1182/blood.V128.22.696.696

Published: 2016

Journal Articles

Major Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors

Eric J Chow, MD MPH, Kara Cushing-Haugen, MS, Wendy Leisenring, ScD, Michael Boeckh, MD, Guang-Shing Cheng, MD, Stephanie J. Lee, MD MPH, Paul J. Martin, MD, Beth Mueller, PhD, Stephen Schwartz, PhD, K. Scott Baker, MD MS

Blood (2014) 124 (21): 431.

https://doi.org/10.1182/blood.V124.21.431.431

Published: 2014

Journal Articles

Influence Of Genetic Variation On Metabolic Outcomes Among Survivors Of Pediatric Hematopoietic Cell Transplantation

Eric J. Chow, MD, MPH, Pamela J. Goodman, MS, Wendy M. Leisenring, ScD, Paul A. Hoffmeister, MPH, Karen W Makar, PhD, Julia Steinberger, MD, K. Scott Baker, MD, MS

Blood (2013) 122 (21): 3319.

https://doi.org/10.1182/blood.V122.21.3319.3319

Published: 2013

Journal Articles

Older Age, Use Of Myeloablative Regimens For Malignant Diseases and Chronic Graft-Versus-Host Disease Are Risk Factors For Avascular Necrosis Of Bone After Allogeneic Hematopoietic Cell Transplantation In Children and Adolescents

Xianxin Li, MD, Ruta Brazauskas, PhD, Zhiwei Wang, MS, Amal Al-Seraihy, K. Scott Baker, MD, MS, Jean-Yves Cahn, MD, Haydar A. Frangoul, MD, James L. Gajewski, MD, Gregory A. Hale, MD, Jack W. Hsu, MD, Rammurti T. Kamble, MD, Hillard M. Lazarus, MD, Richard T. Maziarz, MD, Bipin N. Savani, MD, Ami J. Shah, MD, Mohamed L. Sorror, MD, MSc, William A. Wood, MD, MPH, Navneet S. Majhail, MD, MS

Blood (2013) 122 (21): 917.

https://doi.org/10.1182/blood.V122.21.917.917

Published: 2013

Journal Articles

Long-Term Health-Related Outcomes In Survivors Of Childhood Hematopoietic Cell Transplantation (HCT): A Report From The Bone Marrow Transplant Survivor Study (BMTSS)

Saro Armenian, D.O., M.P.H., Can-Lan Sun, PhD, Mukta Arora, MD, MS, K. Scott Baker, MD, MS, Liton Francisco, Joseph Rosenthal, MD, Daniel Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia, Ph.D.

Blood (2013) 122 (21): 553.

https://doi.org/10.1182/blood.V122.21.553.553

Published: 2013

Journal Articles

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

Michael J Eckrich, MD, MPH, Jennifer Le-Rademacher, PhD, J. Douglas Rizzo, MD, MS, K. Scott Baker, MD, MS, Deepika Bhatla, MD, David K. Buchbinder, M.D., M.S.H.S., Kenneth R. Cooke, MD, Reggie Duerst, MD, Andrew Gilman, MD, Haydar Frangoul, MD, Neena Kapoor, MD, Nancy A. Kernan, MD, Michael Verneris, MD, Mary Eapen, MBBS

Blood (2012) 120 (21): 762.

https://doi.org/10.1182/blood.V120.21.762.762

Published: 2012

Journal Articles

Burden of Morbidity in 10+ Year Survivors of Hematopoietic Cell Transplantation (HCT): A Report From the Bone Marrow Transplant Survivor Study (BMTSS)

Can-Lan Sun, Ph.D, John H. Kersey, MD, Liton Francisco, B.S., K. Scott Baker, MD, MS, Saro H. Armenian, DO, MPH, Daniel J. Weisdorf, MD, Forman Stephen, M.D., Smita Bhatia, MD, MPH

Blood (2011) 118 (21): 841.

https://doi.org/10.1182/blood.V118.21.841.841

Published: 2011

Journal Articles

Identification of Modifiable Factors Associated with Lower Adherence to Preventive Care Practices In HCT Survivors.

Nandita Khera, MD, Eric J. Chow, MD, MPH, Wendy Leisenring, ScD, Karen L Syrjala, PhD, K. Scott Baker, MD, MS, Mary E.D. Flowers, MD, Paul J. Martin, MD, Stephanie J. Lee, MD, MPH

Blood (2010) 116 (21): 3818.

https://doi.org/10.1182/blood.V116.21.3818.3818

Published: 2010

Journal Articles

Long-Term Outcomes In Survivors of Childhood Cancer Treated with Hematopoietic Cell Transplantation (HCT) Versus Conventional Therapy: a Report From the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Saro Armenian, DO, MPH, Can-Lan Sun, Ph.D., Toana Kawashima, MS, Mukta Arora, MD, Wendy Leisenring, ScD, Charles A. Sklar, MD, K. Scott Baker, MD, MS, Liton Francisco, Jennifer Berano Teh, MD, George Mills, III, F. Lennie Wong, PhD, Joseph Rosenthal, MD, Lisa Diller, MD, Melissa M. Hudson, MD, Kevin C. Oeffinger, MD, Leslie L. Robison, PhD, Smita Bhatia, MD, MPH

Blood (2010) 116 (21): 217.

https://doi.org/10.1182/blood.V116.21.217.217

Published: 2010

Journal Articles

Total Body Irradiation (TBI) Increases Cardio-Metabolic Risk and Induces Carotid Vascular Stiffness in Survivors After Hematopoietic Cell Transplant (HCT) for Childhood Hematologic Malignancies.

K. Scott Baker, MD, MS, Lyn Steffen, PhD, Xia Zhou, MS, Aaron Kelly, Ph.D., Jill Lee, RN, MSN, CPNP-AC, Anna Petryk, MD, Alan R. Sinaiko, MD, Donald R. Dengel, PhD, Daniel A. Mulrooney, MD, MS, Julia Steinberger, MD, MS

Blood (2009) 114 (22): 3329.

https://doi.org/10.1182/blood.V114.22.3329.3329

Published: 2009

Journal Articles

Population-Based Analysis of Late Cardiovascular Morbidity and Hospitalizations After Hematopoietic Cell Transplantation.

Eric J Chow, MD, MPH, K. Scott Baker, MD, MS, Debra L. Friedman, MD, MS, Kara Cushing-Haugen, MS, Mary E.D. Flowers, MD, Beth A Mueller, DrPH, Stephanie J. Lee, MD, MPH

Blood (2009) 114 (22): 517.

https://doi.org/10.1182/blood.V114.22.517.517

Published: 2009

Journal Articles

Differential Morbidity by Ethnicity in Long-Term Survivors of Hematopoietic Cell Transplantation (HCT): A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Saro Armenian, DO, MPh, Can-Lan Sun, Liton Francisco, B.S., K. Scott Baker, MD, MS, Stephen J. Forman, Smita Bhatia, MD, MPH

Blood (2008) 112 (11): 454.

https://doi.org/10.1182/blood.V112.11.454.454

Published: 2008

Journal Articles

Outcomes of Pediatric Patients with Respiratory Failure Following Hematopoietic Cell Transplant (HCT); 8 Years’ Experience with High Frequency Oscillatory Ventilation (HFOV).

Scott A Schwantes, MD, Marie E Steiner, MD, Qing Cao, MS, K. Scott Baker, MD, MS, Sameer Gupta, MD

Blood (2008) 112 (11): 1124.

https://doi.org/10.1182/blood.V112.11.1124.1124

Published: 2008

Journal Articles

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

K. Scott Baker, MD, MS, Anna Hassebroek, MPH, Karen Ballen, MD, Carolyn Bigelow, MD, Haydar Frangoul, MD, Cheryl Hardy, PhD, Stephanie Lee, MD,MPH, Galen Switzer, PhD, J. Douglas Rizzo, MD, John P. Klein, PhD, Navneet Majhail, MD,MS, Stella Davies, MB.BS,PhD

Blood (2007) 110 (11): 3064.

https://doi.org/10.1182/blood.V110.11.3064.3064

Published: 2007

Journal Articles

Double Umbilical Cord Blood Transplant Patients Have a Higher Risk of HHV-6 Infection.

Sharon F. Chen, MD, Todd DeFor, MS, Avis J. Thomas, MS, K. Scott Baker, MD, MS

Blood (2006) 108 (11): 5305.

https://doi.org/10.1182/blood.V108.11.5305.5305

Published: 2006

Journal Articles

Hematopoietic Cell Transplantation as Therapy for Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia with and without CNS Involvement.

Paul D. Harker-Murray, MD, PhD, Michael R. Verneris, MD, Avis J. Thomas, MS, Xianghua Luo, PhD, Margaret L. MacMillan, MD, Jakub Tolar, MD, PhD, K. Scott Baker, MD, MS, John E. Wagner, MD, Paul J. Orchard, MD

Blood (2006) 108 (11): 3110.

https://doi.org/10.1182/blood.V108.11.3110.3110

Published: 2006

Journal Articles

Unrelated Donor Hematopoietic Cell Transplant (HCT) for Hemophagocytic Lymphohistiocytosis (HLH).

K. Scott Baker, MD, Mary Eapen, MBBS, Thomas Gross, MD, Gregory A. Hale, MD, Robert Hayashi, MD, Naynesh R. Kamani, MD, Neena Kapoor, MD, Alexandra Filipovich, MD

Blood (2006) 108 (11): 174.

https://doi.org/10.1182/blood.V108.11.174.174

Published: 2006

NARROW

Comparison of Outcomes between HSCT Donor Sources for Pediatric Patients with Hematologic Malignancies

Individualized Treatment Summaries and Survivorship Care Plans (SCPs) for Hematopoietic Cell Transplant (HCT) Survivors Reduces Cancer Treatment Distress in a Randomized, Multicenter Study

Lifestyle Factors and Subsequent Ischemic Heart Disease Risk after Hematopoietic Cell Transplantation

Effect of Dexrazoxane on Heart Function Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report from the Children's Oncology Group (COG)

Major Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors

Influence Of Genetic Variation On Metabolic Outcomes Among Survivors Of Pediatric Hematopoietic Cell Transplantation

Older Age, Use Of Myeloablative Regimens For Malignant Diseases and Chronic Graft-Versus-Host Disease Are Risk Factors For Avascular Necrosis Of Bone After Allogeneic Hematopoietic Cell Transplantation In Children and Adolescents

Long-Term Health-Related Outcomes In Survivors Of Childhood Hematopoietic Cell Transplantation (HCT): A Report From The Bone Marrow Transplant Survivor Study (BMTSS)

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

Burden of Morbidity in 10+ Year Survivors of Hematopoietic Cell Transplantation (HCT): A Report From the Bone Marrow Transplant Survivor Study (BMTSS)

Identification of Modifiable Factors Associated with Lower Adherence to Preventive Care Practices In HCT Survivors.

Long-Term Outcomes In Survivors of Childhood Cancer Treated with Hematopoietic Cell Transplantation (HCT) Versus Conventional Therapy: a Report From the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Total Body Irradiation (TBI) Increases Cardio-Metabolic Risk and Induces Carotid Vascular Stiffness in Survivors After Hematopoietic Cell Transplant (HCT) for Childhood Hematologic Malignancies.

Population-Based Analysis of Late Cardiovascular Morbidity and Hospitalizations After Hematopoietic Cell Transplantation.

Differential Morbidity by Ethnicity in Long-Term Survivors of Hematopoietic Cell Transplantation (HCT): A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Outcomes of Pediatric Patients with Respiratory Failure Following Hematopoietic Cell Transplant (HCT); 8 Years’ Experience with High Frequency Oscillatory Ventilation (HFOV).

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

Double Umbilical Cord Blood Transplant Patients Have a Higher Risk of HHV-6 Infection.

Hematopoietic Cell Transplantation as Therapy for Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia with and without CNS Involvement.

Unrelated Donor Hematopoietic Cell Transplant (HCT) for Hemophagocytic Lymphohistiocytosis (HLH).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only